Ignite Creation Date:
2025-12-25 @ 4:15 AM
Ignite Modification Date:
2026-05-14 @ 3:18 AM
Study NCT ID:
NCT01226420
Status:
TERMINATED
Last Update Posted:
2013-08-13
First Post:
2010-10-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease
Sponsor:
Dana-Farber Cancer Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
10-230
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None